Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Classement en actions #39280
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Prix de l'action
$2.06
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$572.30K
Changement (1 jour)
0.00%
Changement (1 an)
-90.38%
Pays
CA
Échange XORTX Therapeutics Inc. (XRTX)

Catégorie

Historique du prix de l'action pour XORTX Therapeutics Inc. (XRTX)
Prix de clôture le plus élevé : $2.06 le 2026-08-01

Prix de clôture le plus bas : $173.60 le 2015-10-01
Historique du prix de l'action de XORTX Therapeutics Inc. de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 32.51%
US
$857.76 31.47%
NL
$728.31 6.63%
CH
$1.07K -6.40%
KR
$254.43 12.40%
BE